Jun 19 |
How Much Upside is Left in Exscientia (EXAI)? Wall Street Analysts Think 61.43%
|
Jun 10 |
Exscientia: Too Much Pessimism
|
Jun 6 |
Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology
|
Jun 3 |
Can Exscientia (EXAI) Climb 57.17% to Reach the Level Wall Street Analysts Expect?
|
May 30 |
Exscientia to Present at Upcoming Investor Conferences in June
|
May 25 |
Analysts Are Upgrading Exscientia plc (NASDAQ:EXAI) After Its Latest Results
|
May 24 |
Exscientia plc (EXAI) Q1 2024 Earnings Call Transcript
|
May 23 |
The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
|
May 23 |
Exscientia (EXAI) Upgraded to Buy: Here's What You Should Know
|
May 22 |
Regeneron faces new biosimilar threats; An AI biotech lays off staff
|